Compound Camphorine Injection has the efficacy of treating ischemic optic nerve, retina and choroidal lesions, and can effectively promote the recovery of ischemic tissues. Compound Camphorine Injection is a compound preparation class of drugs, and the main potent ingredients it contains include camphorine hydrobromide and procaine hydrochloride. According to modeling tests, the use of this drug can accelerate the restoration of normal levels of vasoactive substances in the ischemic region of the eye as a way to promote the rapid repair of ischemic tissues. Therefore ischemic lesions of the optic nerve, choroid and retina can be treated with the drug. 1. Adverse reactions: A few patients may experience mild dry mouth after using Compound Camptothecin Injection, which usually disappears after a period of time. 2. Contraindications: It is contraindicated for those who are allergic to any of the ingredients contained in the drug. It is contraindicated in patients with cerebral hemorrhage and ocular hemorrhage in the acute phase of the disease. 3. Precautions: The drug should be used with caution in patients with glaucoma and atrial fibrillation. If the treatment with hormone drugs and vasodilator drugs is ineffective, the medication course of Compound Camphorine Injection can be increased appropriately. The use of Compound Camphorine Injection must be completed under the guidance of a professional physician and must not be abused.